Developing Novel, Targeted Immunotherapies for Cancer and Immune Disorders
The Immunotherapy stream highlights the most exciting tools, technologies and engineering strategies driving the development of cellular and non-cellular immunotherapies for cancer and immune disorders. Part One examines recent breakthroughs in T cell
biology, protein engineering and novel IO targets, plus new approaches for improving immunotherapy efficacy and safety. Part Two discusses the latest developments in cellular immunotherapy such as CAR Ts, TCRs, NKs, and TILs, including innovations
in allogenic cellular therapy, gene editing and targeting, all supported by in-depth case studies and clinical data.
Improving Immunotherapy Efficacy and Safety
CAR Ts, TCRs and TILs